• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Mindstrong Sells Tech Assets to SonderMind, Shuts Down Operations

Share:

March 27, 2023

Digital mental health company SonderMind has acquired technology assets from fellow mental health firm Mindstrong, which recently shuttered its headquarters and terminated operations. The deal includes Mindstrong’s technology and some of its tech-related workforce, with around 20 workers being retained by SonderMind. The acquisition will help SonderMind to offer more personalised care journeys, clinical notes templates and improved measurement-based services, as well as enhance its ability to treat patients with serious mental illnesses. Mindstrong was initially focused on developing digital biomarkers to detect early signs of mental illness before adding virtual therapy and care services.

Digital mental health company SonderMind is acquiring Mindstrong’s technology assets months after the fellow mental health firm laid off more than a hundred workers and shuttered its headquarters.

The deal includes Mindstrong’s tech and some of the company’s tech-related workforce. According to reporting by Digital Health Business & Technology, about 20 workers will have jobs at SonderMind. The rest of Mindstrong has terminated operations.

SonderMind said the purchase will allow the company to offer more personalized care journeys, clinical notes templates and improved measurement-based services. It will also add to their ability to treat patients with serious mental illnesses.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Technology has a critical role to play in improving mental healthcare delivery and outcomes, but not on its own,” Mark Frank, CEO and cofounder of SonderMind, said in a statement. “The future of technology-enabled, personalized mental healthcare that we’re building at SonderMind is only possible because of thousands of SonderMind providers. With the addition of Mindstrong technology, we will be equipping clinicians with the clinical capabilities they need – such as tailored care pathways and enhanced measurement-based care – using technology and data to strengthen their ability to deliver high-quality care that helps individuals get better, faster.”

THE LARGER TREND

Founded in 2014, Mindstrong initially focused on developing digital biomarkers to catch early signs of mental illness. Former director of the National Institute of Mental Health Dr. Thomas Insel joined the company in 2017.

It later added virtual therapy and care services, with a focus on serious mental illness. Mindstrong raised $160 million in venture dollars, including a $100 million Series C announced in 2020.

But the changing macroeconomic environment and slowing funding have hit a number of digital health companies, and some firms have pursued layoffs. In January, Mindstrong said it would end its patient care services in March. The company later said it would lay off 128 workers and permanently close its headquarters in Menlo Park, California.

SonderMind also cut 15% of its workforce late last year, according to reporting by Denver Business Journal. It’s been adding acquisitions too; in November, SonderMind said it had purchased Total Brain, a platform that allows users to track their mental capacity, emotions and stress levels.

In 2021, it bought Qntfy, a predictive-analytics platform that uses mental health biometric data to suggest potential treatment options.

Source: MobiHealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Obesity Pipeline Insight Report 2021
  • Alcami Expands Its Sterile Fill-Finish Capacity with Acquisition of TriPharm ServicesAlcami Expands Its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services
  • Global Big Data Enabled Market Key Industry Insights and Segment Analysis Forecast 2020- 2026Global Big Data Enabled Market Key Industry Insights and Segment Analysis Forecast 2020- 2026
  • Tiny Health’s $8.5M Boost | Gut Health Revolution BeginsTiny Health’s $8.5M Boost | Gut Health Revolution Begins
  • LeanTaaS Acquires Hospital IQ, Combined Valuation Exceeds $1BLeanTaaS Acquires Hospital IQ, Combined Valuation Exceeds $1B
  • The U.K. Pharmacovigilance Market Size is Expected to Reach USD 510.37 Million By 2028The U.K. Pharmacovigilance Market Size is Expected to Reach USD 510.37 Million By 2028
  • Zydus Launches Denosumab Biosimilar for CancerZydus Launches Denosumab Biosimilar for Cancer
  • Azurity Pharmaceuticals to Acquire and Merge with Arbor PharmaceuticalsAzurity Pharmaceuticals to Acquire and Merge with Arbor Pharmaceuticals

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications